Denise Weger joined Novartis in 2012. In Global Health and Corporate Responsibility she leads the company’s Materiality Assessment at corporate and country level. In her role as Senior Manager she supports the Strategic Measurement and Materiality Team in various other strategic initiatives such as Novartis’s Impact Valuation efforts. Denise Weger formally represents Novartis at the Value Balancing Alliance to standardize Impact Valuation internationally. Before joining the Corporate Responsibility (CR) strategy team she worked in CR reporting. Denise holds a Bachelor and a Master of Arts in International Affairs and Governance from the University of St. Gallen
